Frontage Holdings, a US-China CRO, raised $205 million in a Hong Kong IPO at a market capitalization of $820 million. China announced plans to audit 77 major pharmaceutical companies over the next …
( read original story …)
The HongKong News
Frontage Holdings, a US-China CRO, raised $205 million in a Hong Kong IPO at a market capitalization of $820 million. China announced plans to audit 77 major pharmaceutical companies over the next …
( read original story …)